Lowering cancer risk and finding cancer earlier
Official title: Program 60: Cancer Risk, Prevention, and Early Detection
Funded at Dana-Farber Cancer Inst · NIH-11322566 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check NIH RePORTER for its current status.
Researchers in Boston are working to prevent cancer and detect it earlier for people in the general population as well as those at higher risk.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11322566 on NIH RePORTER |
Who could benefit from this research
✓Could help
People interested in prevention or early-detection efforts—especially those with higher genetic or clinical risk or with pre-cancerous lesions—would be most relevant to this work.
✕Less likely to help
People with widely metastatic or late-stage cancers are unlikely to receive direct benefit from prevention and early-detection efforts.
What this research studies
This program brings together scientists and clinicians across Dana‑Farber and partner hospitals to stop cancer at its earliest stages and to catch it sooner. Teams combine laboratory biology, population studies, new technologies like AI, and implementation research to turn discoveries into practical care. Work spans the general public, high-risk groups, and people with pre-cancerous changes or targetable mutations. The program also trains new researchers to help move promising tools into community use.
Why it matters
Potential benefit: If successful, this work could lead to earlier cancer detection and new prevention strategies that lower cancer cases and save lives.
How similar studies have gone: Established screening programs have reduced deaths for some cancers, but integrating biomarkers, AI, and community implementation represents a newer, evolving approach.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Syngal, Sapna — Dana-Farber Cancer Inst
- Study coordinator: Syngal, Sapna
Related research
Other NIH-funded projects on the same topics.
-
Helping young people with cancer understand their genetic risks
This study is creating a special program to help teenagers and young adults with hereditary cancer risks learn about their health and make smart choices, while also supporting their families along the way.
-
Core administrative hub for a multifaceted cancer center program
A large, international cancer research program at Dana-Farber aims to advance a curative strategy for multiple myeloma by coordinating translational research, clinical trials, and data analysis.
-
Automated, interactive lab tool to define radiation targets in cancer care
Aims to make it easier and safer to outline the area to treat in radiation therapy for cancers by using smart software and a patient-friendly interface.
-
Cancer Atlas Network data hub to share big cancer data
A national project helps researchers store, harmonize, and share large cancer data collections so doctors and scientists can learn from many patients.
-
Bridge-building cancer research partnership for education, outreach, and science
A joint effort between UMass Boston and Harvard Cancer Consortium to accelerate cancer research and education by connecting lower-resourced institutions with a leading cancer center.
-
NexTGen: Next-Generation T cell therapy for childhood cancers
A charity-friendly overview: researchers at Dana-Farber are developing advanced engineered T-cell therapies to treat pediatric solid cancers like brain tumors and sarcomas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.